Resources Header

Resources Menu

December 29, 2015

MRSA: The Superbug Poised to Cost Hospitals Super Sums

MRSA: The Superbug Poised to Cost Hospitals Super Sums

Hospitals today are increasingly being challenged by rising patient infection rates, especially from “superbugs” such as methicillin-resistant Staphylococcus aureus (MRSA). And the challenges are only going to increase as new Medicare rules go into effect in 2017 that will include MRSA in all reimbursement calculations – potentially costing hospitals hundreds of millions of dollars in lost Medicare reimbursements. This ill-fated financial scenario is currently battled primarily through surface disinfection, which is only moderately effective since bacteria are constantly reintroduced through ventilation systems. The solution to reigning in MRSA infection rates is air-cleaning technology that destroys harmful bacteria in the airstream. By installing such systems now, the results for hospitals will be healthier patients and a better bottom line.

Infection Control Today